Reuters logo
BRIEF-Fibrocell Science Q3 loss per share $‍0.02​
November 13, 2017 / 1:18 PM / 9 days ago

BRIEF-Fibrocell Science Q3 loss per share $‍0.02​

Nov 13 (Reuters) - Fibrocell Science Inc

* Fibrocell reports third quarter 2017 financial results and recent highlights

* Company believes that its cash and cash equivalents at September 30, 2017 will be sufficient to fund operations into Q2 of 2018​

* Fibrocell expects to submit IND application for FCX-013 to FDA in Q4 of 2017, and initiate a human safety clinical trial in 2018​

* Fibrocell Science Inc qtrly loss per share $‍0.02​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below